TBXT and neoplasm: The ligation of PD-1 appears to elicit inhibitory signals that dampen T-cell receptor signaling (75, 76), implicating that high expression of PD-1 which is a co-inhibitory molecule in T cells results in an immunosuppressed status and less function for anti-tumor response leading to progression of tumor and poor outcomes (73, 74, 77).